GL1X · GenesisL1 explorer

Research workbench

NIK bound to inhibitor G02792917

Analyse NIK bound to inhibitor G02792917 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7SZR
Type
protein
Length
649 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.8
Source
Mus musculus
Molecule
Mitogen-activated protein kinase kinase kinase 14
EC
2.7.11.25
UniProt
Q9WUL6
Ligands
DYQ, SO4
Pockets
5 · best druggability 0.81

Structure

x-ray diffraction · resolution 2.8 · 2 distinct chains · 35% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase kinase kinase 14 (EC 2.7.11.25)protein32135% helix, 17% strandQ9WUL6
BMitogen-activated protein kinase kinase kinase 14 (EC 2.7.11.25)protein32834% helix, 17% strandQ9WUL6

Ligands and binding sites

  • DYQ · 1-(3-{[(1R,4R,5S)-4-hydroxy-2-methyl-3-oxo-2-azabicyclo[3.1.0]hexan-4-yl]ethynyl}phenyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111810.810.82115SO4, DYQ
21850.700.8832DYQ
31640.510.7821empty
4730.350.7619empty
5520.290.7514empty

Interfaces

1 interface between chains.

  • A–B · 1237 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • Q9WUL6 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase kinase kinase 14… · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.